MicroRNA test for small testicular masses
Part of Cancer, Hormones & metabolism, Kidney & urinary clinical trials.
This study looks at whether a blood test for microRNAs can help decide if a small testicular mass (a lump or growth) needs surgery or can be safely watched. It aims to avoid unnecessary surgery for benign masses.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a testicular mass that is 2 cm or smaller.
- You are 18 years or older.
- If you have had chemotherapy, the mass appeared after treatment ended.
- You are able to understand and follow the study plan and sign a consent form.
- You do not have cancer that has spread to other parts of the body.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at tiny molecules called microRNAs in the blood of people with either small testicular tumors (less than 2 cm) or leftover lymph node masses after chemotherapy for testicular cancer. The goal is to see if these microRNAs can help guide treatment decisions.
This study looks at tiny genetic signals called microRNAs to see if they can help identify or track testicular cancer. It may help doctors recognize testicular cancer more accurately and decide what to do next.
This trial tests whether a blood test called miRNA-371 can detect active germ cell tumors in patients who have had surgery or are being watched. It may help guide treatment decisions without needing extra biopsies or scans.
This study is looking at a new marker called miRNA371 in people newly diagnosed with germ cell tumors. The goal is to see if it can help predict relapse and guide treatment decisions.
This trial tests a new way to detect tiny molecules called microRNAs in the body. It is looking for healthy volunteers to help see how well the detection works.
This study looks at tiny molecules in your body (microRNA) to help doctors better diagnose pancreatic cancer, predict how it may progress, and understand how it responds to treatment. It may help guide more personalized care in the future.
Hear when a new Testis Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.